FigureĀ 4.
Outcomes of Black and White AYA patients with AML who received different consolidation treatment. DFS (A) and OS (B) of Black and White AYA patients with AML who received consolidation with chemotherapy or autologous HSCT compared with patients who underwent allogeneic HSCT in first CR off-protocol. Only 4 Black patients received an allogeneic HSCT in first CR and are not depicted in the diagram.